1973 年 21 巻 2 号 p. 391-393
The following results have been obtained from our studies of sulfamethoxazole (SMX) -trimethoprim (TMP) combination product in children with bacterial infections :
1. Ten out of 13 cases responded favorably, an effective rate being 77%.
2. This combination product gave particularly impressive results in acute urinary tract infections caused by Escherichia coli.
3. In patients with bacterial infection of the respiratory tract, clinical response started with a prompt normalization of fever followed by an improvement in other clinical features and laboratory findings. The foregoing experience encourages further trial of this combination product in various infections of bacterial origin in the pediatric field including more serious infections.